Emergent BioSolutions (EBS) Enterprise Value: 772.03M

Emergent BioSolutions, Inc. (EBS)

6.33 -0.04 (-0.63%) USD | NYSE | Oct 02, 16:00

6.335 0.00 (0.00%) Pre-Market: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2006. Start Trial.

Date	Value
October 02, 2026	772.03M
October 01, 2026	774.08M
September 30, 2026	785.88M
September 29, 2026	802.30M
September 28, 2026	799.22M
September 25, 2026	795.63M
September 24, 2026	794.60M
September 23, 2026	789.47M
September 22, 2026	794.09M
September 21, 2026	783.32M
September 18, 2026	796.14M
September 17, 2026	807.43M
September 16, 2026	793.58M
September 15, 2026	773.57M
September 14, 2026	774.59M
September 11, 2026	766.90M
September 10, 2026	748.43M
September 09, 2026	738.68M
September 08, 2026	755.10M
September 04, 2026	765.87M
September 03, 2026	766.90M
September 02, 2026	778.70M
September 01, 2026	766.39M
August 31, 2026	760.23M
August 28, 2026	750.48M

Date	Value
August 27, 2026	752.02M
August 26, 2026	753.56M
August 25, 2026	736.63M
August 24, 2026	713.03M
August 21, 2026	707.90M
August 20, 2026	694.57M
August 19, 2026	698.16M
August 18, 2026	686.36M
August 17, 2026	678.15M
August 14, 2026	682.77M
August 13, 2026	677.64M
August 12, 2026	680.72M
August 11, 2026	675.58M
August 10, 2026	676.61M
August 07, 2026	695.59M
August 06, 2026	719.70M
August 05, 2026	834.10M
August 04, 2026	835.64M
August 03, 2026	827.43M
July 31, 2026	817.69M
July 30, 2026	819.74M
July 29, 2026	824.36M
July 28, 2026	822.30M
July 27, 2026	823.33M
July 24, 2026	819.74M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks